Fundamental and Clinical Pharmacology · 2012 · 34 citations · 41 references
MedicineCardiologyPharmacologyCardiovascular PharmacotherapyClinical CardiologyExercise TestingCardiac BiomarkersCardiac MedicationsCardiac PharmacotherapyCardiac PhysiologyHeart FailureHeart Failure PharmacotherapyAdenosine Triphosphate MetabolismCellular Energy BalanceCellular Energy SensingLeft Ventricular PhysiologyLeft Ventricular Systolic FunctionMetabolic Equivalent AssessmentRate-pressure ProductVentricular Ejection Fraction Assessment
Beta-blockers have been shown to improve left ventricular (LV) function in patients with heart failure. The aim of this study is to non-invasively assess, by means of in vivo 31P-magnetic resonance spectroscopy (31P-MRS), the effects of beta-blockers on LV cardiac phosphocreatine and adenosine triphosphate (PCr/ATP) ratio in patients with heart failure. Ten heart failure patients on full medical therapy were beta-blocked by either carvedilol or bisoprolol. Before and after 3 months of treatment, exercise testing, 2D echocardiography, MRS, New York Heart Association (NYHA) class, ejection fraction (EF), maximal rate-pressure product and exercise metabolic equivalent system (METS) were evaluated. Relative concentrations of PCr and ATP were determined by cardiac 31P-MRS. After beta-blockade, NYHA class decreased (from 2.2 ± 0.54 to 1.9 ± 0.52, P = 0.05), whereas EF (from 33 ± 7 to 44 ± 6%, P = 0.0009) and METS (from 6.74 ± 2.12 to 8.03 ± 2.39, P = 0.01) increased. Accordingly, the mean cardiac PCr/ATP ratio increased by 33% (from 1.48 ± 0.22 to 1.81 ± 0.48, P = 0.03). Beta-blockade-induced symptomatic and functional improvement in patients with heart failure is associated to increased PCr/ATP ratio, indicating preservation of myocardial high-energy phosphate levels.
41
The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial
The Lancet · 1999 · 4.9K citations
Medicine, Cardiology, Pharmacology +10
Effect of Carvedilol on Survival in Severe Chronic Heart Failure
Milton Packer, Andrew J.S. Coats, Michael B. Fowler et al. · New England Journal of Medicine · 2001 · 3.1K citations · Full text
Medicine, Cardiology, Pharmacology +11